This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Authoring team

It occurs in children under 2 years of age and most commonly in the first year of life, peaking between 3 and 6 months.

  • symptoms usually peak between 3 and 5 days, and that cough resolves in 90% of infants within 3 weeks
  • bronchiolitis can be diagnosed if the child has a coryzal prodrome lasting 1 to 3 days, followed by:
    • persistent cough and either tachypnoea or chest recession (or both)
    • and either wheeze or crackles on chest auscultation (or both)
  • following symptoms are common in children with this disease:
    • fever (in around 30% of cases, usually of less than 39°C)
    • poor feeding (typically after 3 to 5 days of illness)
  • young infants with this disease (in particular those under 6 weeks of age) may present with apnoea without other clinical signs

  • in a mild illness the child may improve. However in some cases the condition progresses with increasing breathlessness, wheeze, cyanosis and pyrexia
  • in severe illness on examination the child has rapid, laboured breathing, tachycardia, gross lung hyperinflation producing a barrel-shaped chest, prominent neck veins and downward displacement of the liver. Auscultation reveals widespread wheeze and crepitations over both lung fields. There is increased expiratory time

  • consider a diagnosis of pneumonia if the child has:
    • high fever (over 39°C)
    • and/or persistently focal crackles

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.